Marked Clinical Improvement in Parkinson's Disease Following Double-Filtration Apheresis: A Case Report. [PDF]
Burgard H.
europepmc +1 more source
The Role of Uremic Toxins in Comorbidities of Chronic Kidney Disease. [PDF]
Yamamoto S.
europepmc +1 more source
Lipoprotein(a) in cardiovascular disease: pathophysiology, residual risk, and emerging therapeutic strategies. [PDF]
Granata LG +5 more
europepmc +1 more source
Current and Future Perspectives of LDL-C Lowering Therapies 2026. [PDF]
Tada H, Sakata K, Usui S, Takamura M.
europepmc +1 more source
Treatment-resistant PLA2R-negative membranous nephropathy responsive to low-density lipoprotein apheresis. [PDF]
Szymanski JM +3 more
europepmc +1 more source
Pelacarsen and lipoprotein(a) apheresis in secondary prevention: the Lp(a)FRONTIERS APHERESIS trial. [PDF]
Parhofer KG +14 more
europepmc +1 more source
Clinical and genetic characterization of homozygous <i>LDLR</i> variants in familial hypercholesterolaemia: insights from two case reports. [PDF]
Sahoo SK +7 more
europepmc +1 more source
Managing Progressive Atherosclerotic Cardiovascular Disease in a Patient with Elevated Lipoprotein(a). [PDF]
Yurtseven E, Tokgözoğlu L.
europepmc +1 more source

